Oncologic outcomes

Dipen J Parekh, G. Andy Ransford, George S. Kallingal

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

As robot-assisted radical cystectomy (RARC) is emerging as a viable surgical technique for bladder cancer, it is imperative to evaluate oncologic outcomes as it compares to the gold standard of open radical cystectomy (ORC). For cancer-specific survival and recurrence-free survival, long-term data is lacking; however, medium-term data shows similar cancer-specific survival and overall survival with median follow-up as far out as 3 years. With regards to surrogates for oncologic efficacy, namely surgical margin status and lymph node yield, we present collective data from several large RARC series showing comparable rates of positive surgical margins and similar lymph node yields. We also examine several head to head comparisons of RARC compared to open radical cystectomy, which show similar oncologic outcomes. As long term data matures and more randomized controlled studies directly comparing RARC to ORC come to fruition, we will have more data potentially confirming that RARC provides equivalent oncologic outcomes to ORC.

Original languageEnglish (US)
Title of host publicationRobotic Surgery of the Bladder
PublisherSpringer New York
Pages137-144
Number of pages8
Volume9781461449065
ISBN (Print)9781461449065, 1461449057, 9781461449058
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Cystectomy
Lymph Nodes
Urinary Bladder Neoplasms
Neoplasms
Recurrence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Parekh, D. J., Ransford, G. A., & Kallingal, G. S. (2014). Oncologic outcomes. In Robotic Surgery of the Bladder (Vol. 9781461449065, pp. 137-144). Springer New York. https://doi.org/10.1007/978-1-4614-4906-5_14

Oncologic outcomes. / Parekh, Dipen J; Ransford, G. Andy; Kallingal, George S.

Robotic Surgery of the Bladder. Vol. 9781461449065 Springer New York, 2014. p. 137-144.

Research output: Chapter in Book/Report/Conference proceedingChapter

Parekh, DJ, Ransford, GA & Kallingal, GS 2014, Oncologic outcomes. in Robotic Surgery of the Bladder. vol. 9781461449065, Springer New York, pp. 137-144. https://doi.org/10.1007/978-1-4614-4906-5_14
Parekh DJ, Ransford GA, Kallingal GS. Oncologic outcomes. In Robotic Surgery of the Bladder. Vol. 9781461449065. Springer New York. 2014. p. 137-144 https://doi.org/10.1007/978-1-4614-4906-5_14
Parekh, Dipen J ; Ransford, G. Andy ; Kallingal, George S. / Oncologic outcomes. Robotic Surgery of the Bladder. Vol. 9781461449065 Springer New York, 2014. pp. 137-144
@inbook{ef71add102554753b71f55f2aad0d395,
title = "Oncologic outcomes",
abstract = "As robot-assisted radical cystectomy (RARC) is emerging as a viable surgical technique for bladder cancer, it is imperative to evaluate oncologic outcomes as it compares to the gold standard of open radical cystectomy (ORC). For cancer-specific survival and recurrence-free survival, long-term data is lacking; however, medium-term data shows similar cancer-specific survival and overall survival with median follow-up as far out as 3 years. With regards to surrogates for oncologic efficacy, namely surgical margin status and lymph node yield, we present collective data from several large RARC series showing comparable rates of positive surgical margins and similar lymph node yields. We also examine several head to head comparisons of RARC compared to open radical cystectomy, which show similar oncologic outcomes. As long term data matures and more randomized controlled studies directly comparing RARC to ORC come to fruition, we will have more data potentially confirming that RARC provides equivalent oncologic outcomes to ORC.",
author = "Parekh, {Dipen J} and Ransford, {G. Andy} and Kallingal, {George S.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1007/978-1-4614-4906-5_14",
language = "English (US)",
isbn = "9781461449065",
volume = "9781461449065",
pages = "137--144",
booktitle = "Robotic Surgery of the Bladder",
publisher = "Springer New York",

}

TY - CHAP

T1 - Oncologic outcomes

AU - Parekh, Dipen J

AU - Ransford, G. Andy

AU - Kallingal, George S.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - As robot-assisted radical cystectomy (RARC) is emerging as a viable surgical technique for bladder cancer, it is imperative to evaluate oncologic outcomes as it compares to the gold standard of open radical cystectomy (ORC). For cancer-specific survival and recurrence-free survival, long-term data is lacking; however, medium-term data shows similar cancer-specific survival and overall survival with median follow-up as far out as 3 years. With regards to surrogates for oncologic efficacy, namely surgical margin status and lymph node yield, we present collective data from several large RARC series showing comparable rates of positive surgical margins and similar lymph node yields. We also examine several head to head comparisons of RARC compared to open radical cystectomy, which show similar oncologic outcomes. As long term data matures and more randomized controlled studies directly comparing RARC to ORC come to fruition, we will have more data potentially confirming that RARC provides equivalent oncologic outcomes to ORC.

AB - As robot-assisted radical cystectomy (RARC) is emerging as a viable surgical technique for bladder cancer, it is imperative to evaluate oncologic outcomes as it compares to the gold standard of open radical cystectomy (ORC). For cancer-specific survival and recurrence-free survival, long-term data is lacking; however, medium-term data shows similar cancer-specific survival and overall survival with median follow-up as far out as 3 years. With regards to surrogates for oncologic efficacy, namely surgical margin status and lymph node yield, we present collective data from several large RARC series showing comparable rates of positive surgical margins and similar lymph node yields. We also examine several head to head comparisons of RARC compared to open radical cystectomy, which show similar oncologic outcomes. As long term data matures and more randomized controlled studies directly comparing RARC to ORC come to fruition, we will have more data potentially confirming that RARC provides equivalent oncologic outcomes to ORC.

UR - http://www.scopus.com/inward/record.url?scp=84949175765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949175765&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-4906-5_14

DO - 10.1007/978-1-4614-4906-5_14

M3 - Chapter

SN - 9781461449065

SN - 1461449057

SN - 9781461449058

VL - 9781461449065

SP - 137

EP - 144

BT - Robotic Surgery of the Bladder

PB - Springer New York

ER -